"Moving marijuana from Schedule I to Schedule III, without other legal changes, would not bring the state-legal medical or recreational marijuana industry into compliance with federal controlled substances law. With respect to medical marijuana, a key difference between placement in Schedule I and Schedule III is that substances in Schedule III have an accepted medical use and may lawfully be dispensed by prescription, while Substances in Schedule I cannot. However, prescription drugs must be approved by the Food and Drug Administration (FDA).

"Slightly less than half of all sworn SROs reported that they had confiscated drugs (45%) within the past 30 days (figure 6). Nearly 4 in 10 SROs had made an arrest (39%) or issued a criminal citation (37%) in the past 30 days. About 23% of SROs had confiscated a weapon.

"About 83% of sworn SROs had conducted video surveillance of schools in the past 30 days (table 7). About half of all SROs had conducted security audits or assessments of school campuses (51%) or monitored social media (47%). About 45% of SROs had participated in crisis preparedness training or on a threat assessment team.

"About 83% of all sworn SROs were male, and 17% were female (table 2). In both local police departments and sheriffs’ offices, 84% of SROs were male and 16% were female. In school district police departments, 81% of SROs were male and 19% were female. There were no statistically significant differences by agency type in the percentages of male SROs or female SROs.

"At the end of the 2019–2020 school year, there were approximately 23,400 sworn school resource officers (SROs) in the United States (figure 1, table 1).¹ About 11,500 (49%) of these SROs were employed by local police departments, 7,600 (32%) were employed by sheriffs’ offices, and 4,400 (19%) were employed by school district police departments."

"Among 207,781 national YRBS [Youth Risk Behavioral Survey] respondents (mean [SD] age, 16.04 [1.23] years; 50.90% male), 13.35% were Black or African American, 17.09% were Hispanic, and 60.13% were non-Hispanic White. Among 1 549 075 state YRBS respondents (mean [SD] age, 16.01 [1.23] years; 50.20% male), 16.53% were Black or African American, 17.78% were Hispanic, and 58.09% were non-Hispanic White.

"Cannabinoid agonist treatment is unlikely to be an approach relevant to all cannabis users seeking treatment, as evidenced by the large numbers of individuals who did not complete the study screening process, and the modest 12-week treatment retention rates. Whereas nicotine-agonist and opioid-agonist treatments are considered front-line therapies, our findings suggest a more cautious approach for cannabinoid agonist treatment at this time.

"Early implementation issues and tensions included prescriber concerns about safer supply prescribing in a highly politicized environment, accessibility challenges for service users such as stigma, encampment displacement, OAT requirements, program capacity and costs, and tensions between addiction medicine and harm reduction. Navigating these tensions included development of clinical protocols, innovations to reduce accessibility challenges such as outreach, wraparound care, program coverage of medication costs and prescribing safer supply with/without OAT.

"From 2016–2017 to 2020–2021, the average annual number of U.S. deaths from excessive alcohol use increased by more than 40,000 (29%), from approximately 138,000 per year (2016–2017) to 178,000 per year (2020–2021). This increase translates to an average of approximately 488 deaths each day from excessive drinking during 2020–2021.

"In conclusion, we found that areas where SCS were implemented in Toronto subsequently had significant reductions in overdose mortality incidence, although other areas in the city did not. Furthermore, we found an inverse spatial association between SCS and overdose mortality incident locations, and this association increased in magnitude over time. This finding suggests that the implementation of SCS could contribute to reductions in overdose mortality in proximal areas.